Regulacje i polityka gospodarcza · 15/09/1998

National Cancer Institute Seeks Pharmaceutical Companies for Cooperative Research and Development Agreements for Anti-Angiogenic Cancer Treatments

The National Cancer Institute is seeking pharmaceutical or biotechnology companies to collaborate on Cooperative Research and Development Agreements (CRADAs) for the development and evaluation of chemokine or chemokine receptor neutralizing antibodies with anti-angiogenic effects, which could lead to new cancer treatments.